一氧化碳与一氧化氮联合肺转移检测未改善系统性硬化相关肺动脉高压的识别
该回顾性多中心研究纳入572例系统性硬化患者,其中58例经右心导管确诊肺动脉高压。比较一氧化碳肺转移因子(TLCO)与一氧化氮肺转移因子(TLNO)联合分区检测与单用TLCO识别肺动脉高压的能力,结果显示两者ROC曲线下面积相当(TLCO 0.82,TLNO 0.80),联合检测并未优于单用TLCO。
要点
- 在系统性硬化患者中,单用TLCO识别肺动脉高压的AUC为0.82,与TLNO相当。
- TLCO-TLNO联合分区检测并未提高对肺动脉高压的识别能力。
- 膜弥散量(DMCO)与肺泡毛细血管血容量(VC)的识别能力低于TLCO。
核心结论
- 与单用TLCO相比,联合TLCO-TLNO检测并不能增加在未选择的系统性硬化患者中识别肺动脉高压的能力。
研究设计与样本
- 回顾性研究,在法国七个中心连续纳入572例未选择的系统性硬化患者,其中58例经右心导管确诊肺动脉高压。
主要发现
- 系统性硬化合并肺动脉高压患者的TLCO、TLNO和VC均低于无肺动脉高压患者。
- 识别肺动脉高压的ROC曲线下面积:TLCO为0.82(95%CI 0.79-0.85),TLNO为0.80(95%CI 0.76-0.83),VC为0.75(95%CI 0.71-0.78),DMCO为0.66(95%CI 0.62-0.70)。
临床怎么用
- 在系统性硬化患者中筛查肺动脉高压时,联合TLCO-TLNO分区检测并未显示出优于单用TLCO的识别能力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Screening is important to determine whether patients with systemic sclerosis (SSc) have pulmonary hypertension because earlier pulmonary hypertension treatment can improve survival in these patients. Although decreased transfer factor of the lung for carbon monoxide (TLCO) is currently considered the best pulmonary function test for screening for pulmonary hypertension in SSc, small series have suggested that partitioning TLCO into membrane conductance (diffusing capacity) for carbon monoxide (DMCO) and alveolar capillary blood volume (VC) through combined measurement of TLCO and transfer factor of the lung for nitric oxide (TLNO) is more effective to identify pulmonary hypertension in SSc patients compared with TLCO alone. Here, the objective was to determine whether combined TLCO-TLNO partitioned with recently refined equations could more accurately detect pulmonary hypertension than TLCO alone in SSc.For that purpose, 572 unselected consecutive SSc patients were retrospectively recruited in seven French centres.Pulmonary hypertension was diagnosed with right heart catheterisation in 58 patients. TLCO, TLNO and VC were all lower in SSc patients with pulmonary hypertension than in SSc patients without pulmonary hypertension. The area under the receiver operating characteristic curve for the presence of pulmonary hypertension was equivalent for TLCO (0.82, 95% CI 0.79-0.85) and TLNO (0.80, 95% CI 0.76-0.83), but lower for VC (0.75, 95% CI 0.71-0.78) and DMCO (0.66, 95% CI 0.62-0.70).Compared with TLCO alone, combined TLCO-TLNO does not add capability to detect pulmonary hypertension in unselected SSc patients.
引用
- Degano B, Soumagne T, Delaye T, et al. Combined measurement of carbon monoxide and nitric oxide lung transfer does not improve the identification of pulmonary hypertension in systemic sclerosis. Eur Respir J. 2017. PMID: 29051271. doi:10.1183/13993003.01008-2017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。